Warning that certain generics could disappear from German market

Attempts to curb drug shortages in Germany may not be sufficient to prevent a crisis, the government has been warned.

Euractiv has reported on the government’s draft law aimed at avoiding drug shortages in the face of spiralling production costs, but its report also identified that the generics industry is not convinced that the plans go far enough.

Drugs impacted by the shortages in Germany have included children’s medicines to treat common conditions such as fever and pain.